---
figid: PMC9168372__fphar-13-883857-g002
figtitle: 'Anti-Inflammatory Activities of Betulinic Acid: A Review'
organisms:
- Saccharomyces cerevisiae
- PX clade
- Bryophyta
- Nelumbo nucifera
- Betula pendula
- Diospyros kaki
- Prunella vulgaris
- Scoparia dulcis
- Solanum virginianum
- Diospyros leucomelas
- Alphitonia zizyphoides
- Erythrophleum ivorense
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Bos taurus
- Gallus gallus
- Plasmodium falciparum
organisms_ner:
- Rattus norvegicus
- Bos taurus
- Homo sapiens
- Gallus gallus
- Mus musculus
- Drosophila melanogaster
- Danio rerio
pmcid: PMC9168372
filename: fphar-13-883857-g002.jpg
figlink: /pmc/articles/PMC9168372/figure/F2/
number: F2
caption: Immunomodulatory activities of betulinic acid in vitro. Betulinic acid (BA)
  has a broad-spectrum anti-inflammatory activity, significantly increasing IL-10
  production, decreasing ICAM-1, VCAM-1, and E-selectin expression and inhibiting
  nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), leading
  to downregulation of several pro-inflammatory genes. BA blocks the NF-κB signaling
  pathway by inhibiting IκB phosphorylation and degradation through ubiquitination
  via the proteasome degradation machinery. As a result, NF-κB is not activated and
  does not translocate from the cytoplasm to the nucleus, impeding the transcription
  of pro-inflammatory mediators such as IL-1β, IL-6, IL-12, NO, PGE2, and TNF. Created
  with BioRender.com.
papertitle: 'Anti-Inflammatory Activities of Betulinic Acid: A Review.'
reftext: José Fernando Oliveira-Costa, et al. Front Pharmacol. 2022;13:883857.
year: '2022'
doi: 10.3389/fphar.2022.883857
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: betulinic acid | anti-inflammatory activity | terpenoids | immunomodulation
  | inflammation
automl_pathway: 0.9664234
figid_alias: PMC9168372__F2
figtype: Figure
redirect_from: /figures/PMC9168372__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9168372__fphar-13-883857-g002.html
  '@type': Dataset
  description: Immunomodulatory activities of betulinic acid in vitro. Betulinic acid
    (BA) has a broad-spectrum anti-inflammatory activity, significantly increasing
    IL-10 production, decreasing ICAM-1, VCAM-1, and E-selectin expression and inhibiting
    nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), leading
    to downregulation of several pro-inflammatory genes. BA blocks the NF-κB signaling
    pathway by inhibiting IκB phosphorylation and degradation through ubiquitination
    via the proteasome degradation machinery. As a result, NF-κB is not activated
    and does not translocate from the cytoplasm to the nucleus, impeding the transcription
    of pro-inflammatory mediators such as IL-1β, IL-6, IL-12, NO, PGE2, and TNF. Created
    with BioRender.com.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Syt1
  - Rel
  - Npc2
  - Il10
  - Nfkb1
  - Icam1
  - Vcam1
  - Tnf
  - Il12b
  - Il13
  - Il6
  - REL
  - IL10
  - ICAM1
  - VCAM1
  - TNF
  - IL13
  - IL6
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - NFKB1
  - IL12A
  - IL12B
  - DCTN2
  - SELE
  - Rela
  - Gorasp1
  - Cdc37
  - Lsp1
  - Pold2
  - Cd40
  - Dctn2
  - Nfkbib
  - Sele
  - dl
  - wash
  - Hrb27C
  - betaTub60D
  - Rpt5
  - DCTN2-p50
  - Dif
  - mo
  - egr
  - Ugt36A1
  - rela
  - rel
  - nfkb1
  - il10
  - vcam1b
  - sele
  - tnfrsfa
  - tnfb
  - il13
  - il6
---
